Glenmark gets okay for generic acne solution
PARAMUS, N.J. – Glenmark Pharmaceuticals has received the Food and Drug Administration’s approval for generic BenzaClin (clindamycin and benzoyl peroxide gel, 1%/5%). The product, which is an acne treatment, is a generic of Valeant Bermuda’s branded product. BenzaClin gel, 1%/5% had a market value of approximately $99.4 million for the 12 month period ended January
